Higher Cumulative Live Birth Rate but Also Higher Late Miscarriage Risk in Non-Obese Women with Polycystic Ovary Syndrome Undergoing the First IVF/ICSI Cycle

被引:0
作者
Liu, Simin [1 ,2 ]
Zhou, Xiu [1 ,2 ]
Jie, Huiying [1 ,2 ]
Zheng, Zetong [1 ,2 ]
Cai, Bing [1 ,2 ]
Mai, Qingyun [1 ,2 ,3 ]
Zhou, Canquan [1 ,2 ,3 ,4 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, Guangzhou, Peoples R China
[2] Guangdong Prov Key Lab Reprod Med, Guangzhou, Peoples R China
[3] Guangdong Prov Clin Res Ctr Obstetr & Gynecol Dis, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Reprod Med Ctr, 1 Zhongshan Second Rd, Guangzhou 510080, Peoples R China
来源
INTERNATIONAL JOURNAL OF WOMENS HEALTH | 2024年 / 16卷
关键词
body mass index; cumulative live birth rate; in vitro fertilization; intracytoplasmic sperm injection; late miscarriage; polycystic ovary syndrome; DIAGNOSTIC-CRITERIA; TROPHOBLAST INVASION; INSULIN-RESISTANCE; EMBRYO-TRANSFER; OBESITY; FRESH; PCOS; STIMULATION; PREVALENCE; MANAGEMENT;
D O I
10.2147/IJWH.S445021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose: To determine the impact of polycystic ovary syndrome on in vitro fertilization/intracytoplasmic sperm injection and embryo transfer outcomes while analyzing the influencing factors. Patients and Methods: A retrospective cohort study comprised 4839 patients who underwent their first cycle of IVF/ICSI treatment from January 2016 to December 2021. Cumulative pregnancy rates, cumulative live birth rates, and late miscarriage rates compared between the PCOS group and control group. Subgroup analysis and binary regression were used to analyze the influence of BMI on clinical outcomes among individuals diagnosed with PCOS. Results: Non -obese PCOS patients exhibited higher cumulative pregnancy rates, cumulative live birth rates, and late miscarriage rates compared to the control group with the normal BMI population (84.7% vs71.2%, P < 0.001; 74.1% vs 61.6%, P < 0.001; 4.1% vs 2.0%, P = 0.002), but there was no significant difference in early miscarriage rates between the two groups. Conclusion: Non -obese PCOS patients demonstrated a notably higher cumulative live birth rate but also a higher risk of late miscarriage compared to non-PCOS females with a normal BMI.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 74 条
  • [1] Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome
    Ademoglu, Esra Nur
    Gorar, Suheyla
    Carlioglu, Ayse
    Yazici, Havva
    Dellal, Fatma Dilek
    Berberoglu, Zehra
    Akdeniz, Derya
    Uysal, Sema
    Karakurt, Feridun
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (08) : 715 - 719
  • [2] Polycystic ovary syndrome
    Azziz, Ricardo
    Carmina, Enrico
    Chen, ZiJiang
    Dunaif, Andrea
    Laven, Joop S. E.
    Legro, Richard S.
    Lizneva, Daria
    Natterson-Horowtiz, Barbara
    Teede, Helena J.
    Yildiz, Bulent O.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2016, 2
  • [3] The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
    Balen, Adam H.
    Morley, Lara C.
    Misso, Marie
    Franks, Stephen
    Legro, Richard S.
    Wijeyaratne, Chandrika N.
    Stener-Victorin, Elisabet
    Fauser, Bart C. J. M.
    Norman, Robert J.
    Teede, Helena
    [J]. HUMAN REPRODUCTION UPDATE, 2016, 22 (06) : 687 - 708
  • [4] The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
    Bozdag, Gurkan
    Mumusoglu, Sezcan
    Zengin, Dila
    Karabulut, Erdem
    Yildiz, Bulent Okan
    [J]. HUMAN REPRODUCTION, 2016, 31 (12) : 2841 - 2855
  • [5] Early and late pregnancy loss in women with polycystic ovary syndrome undergoing IVF/ICSI treatment: a retrospective cohort analysis of 21 820 pregnancies
    Cai, He
    Mol, B. W.
    Gordts, S.
    Wang, H.
    Wang, T.
    Li, N.
    Shi, J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (07) : 1160 - 1169
  • [6] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [7] Prenatal androgen induced lean PCOS impairs mitochondria and mRNA profiles in oocytes
    Chappell, Neil R.
    Zhou, Beth
    Schutt, Amy K.
    Gibbons, William E.
    Blesson, Chellakkan S.
    [J]. ENDOCRINE CONNECTIONS, 2020, 9 (03) : 261 - 270
  • [8] Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome
    Chen, Zi-Jiang
    Shi, Yuhua
    Sun, Yun
    Zhang, Bo
    Liang, Xiaoyan
    Cao, Yunxia
    Yang, Jing
    Liu, Jiayin
    Wei, Daimin
    Weng, Ning
    Tian, Lifeng
    Hao, Cuifang
    Yang, Dongzi
    Zhou, Feng
    Shi, Juanzi
    Xu, Yongle
    Li, Jing
    Yan, Junhao
    Qin, Yingying
    Zhao, Han
    Zhang, Heping
    Legro, Richard S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (06) : 523 - 533
  • [9] Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
    Dapas, Matthew
    Dunaif, Andrea
    [J]. ENDOCRINE REVIEWS, 2022, 43 (06) : 927 - 965
  • [10] Current and experimental drug therapy for the treatment of polycystic ovarian syndrome
    Della Corte, Luigi
    Foreste, Virginia
    Barra, Fabio
    Gustavino, Claudio
    Alessandri, Franco
    Centurioni, Maria Grazia
    Ferrero, Simone
    Bifulco, Giuseppe
    Giampaolino, Pierluigi
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 819 - 830